APRE Competitors & Alternatives
Compare Aprea Therapeutics Inc with similar stocks in the same industry
Biotechnology
APRE
Main Stock$0.69
Tradestie Score
49
Market Cap
$8.50M
Revenue Growth
-1.0%
Analyst Upside
+523.2%
Top Competitors
232 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
NVCT
Nuvectis Pharma, Inc. Common Stock
|
$18.60
|
$154.27M | - | 52 | Compare |
|
CLYM
Climb Bio, Inc. Common Stock
|
$12.58
|
$133.50M | - | 50 | Compare |
|
STTK
Shattuck Labs, Inc. Common Stock
|
$7.07
|
$114.01M | - | 60 | Compare |
|
ANRO
Alto Neuroscience Inc.
|
$27.33
|
$110.20M | - | 64 | Compare |
|
BYSI
BeyondSpring Inc. Ordinary Shares
|
$1.28
|
$72.18M | - | 47 | Compare |
|
RLMD
Relmada Therapeutics, Inc. Common Stock
|
$5.46
|
$71.69M | - | 43 | Compare |
|
IMMX
Immix Biopharma, Inc. Common Stock
|
$10.06
|
$67.94M | - | 56 | Compare |
|
CYCN
Cyclerion Therapeutics, Inc. Common Stock
|
$3.66
|
$7.59M | - | 55 | Compare |
|
GRTX
GRTX
|
- | - | - | - | Compare |
|
ATXI
ATXI
|
- | - | - | - | Compare |
More APRE Analysis
Data updated: Jul 16, 2026 | Industry: Biotechnology (SIC 2834)
232 stocks in this industry